NIVA BUPA HEALTH INS CO L (NIVABUPA) financials
NIVA BUPA HEALTH INS CO L (NIVABUPA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
- Market Cap: ₹14,239Cr.
- Current Price: ₹77.0
- Stock P/E: 81.7
- ROE: 3.46%
- ROCE: 3.15%
- Book Value: ₹20.5
- Dividend Yield: 0.00%
- 52W High / Low: ₹91.4/67.5
In Jun 2026, NIVA BUPA HEALTH INS CO L (NIVABUPA) reported sales ₹2,471 Cr and net profit ₹138 Cr.
Annual TTM: sales ₹7,907 Cr, net profit ₹174 Cr.
Shareholding: Promoters 55.30% (Jun 2026), FIIs 12.09% (Jun 2026), DIIs 16.17% (Jun 2026), Public 16.44% (Jun 2026), No. of Shareholders 1,26,567% (Jun 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,321 | 1,258 | 1,671 | 1,932 | 1,574 | 1,611 | 2,251 | 2,471 |
| Expenses | 1,387 | 1,282 | 1,420 | 1,834 | 1,627 | 1,705 | 2,069 | 2,287 |
| Operating Profit | -66 | -24 | 251 | 98 | -53 | -94 | 182 | 184 |
| OPM % | -5.0% | -1.9% | 15% | 5% | -3.4% | -6% | 8% | 7% |
| Other Income | 79 | 37 | -45 | -0 | 18 | 7 | -1 | -0 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Depreciation | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Profit before tax | 13 | 13 | 206 | 98 | -35 | -88 | 181 | 184 |
| Tax % | -0% | -0% | -0% | 27% | -0% | -0% | 12% | 25% |
| Net Profit | 13 | 13 | 206 | 71 | -35 | -88 | 159 | 138 |
| EPS in Rs | — | 0.07 | 1.13 | 0.39 | -0.19 | -0.47 | 0.86 | 0.75 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,057 | 1,413 | 1,877 | 2,853 | 4,115 | 5,374 | 6,695 | 7,907 |
| Expenses | 1,094 | 1,435 | 2,328 | 3,183 | 4,228 | 5,292 | 6,534 | 7,689 |
| Operating Profit | -37 | -22 | -451 | -330 | -113 | 83 | 160 | 218 |
| OPM % | -3.5% | -1.5% | -24% | -12% | -2.7% | 1.5% | 2.4% | 2.8% |
| Other Income | 0 | 0 | 281 | 374 | 224 | 155 | 2 | 23 |
| Interest | 4 | 6 | -0 | -0 | -0 | -0 | -0 | 0 |
| Depreciation | 21 | 22 | 27 | 32 | 29 | 25 | 36 | 0 |
| Profit before tax | -62 | -50 | -197 | 13 | 82 | 214 | 127 | 242 |
| Tax % | -0% | -0% | -0% | -0% | -0% | -0% | -3% | — |
| Net Profit | -62 | -50 | -197 | 13 | 82 | 214 | 131 | 174 |
| EPS in Rs | — | — | — | — | — | 1.17 | 0.71 | 0.95 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 981 | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 | 1,847 |
| Reserves | -719 | -780 | -773 | -903 | -683 | 351 | 1,949 | 1,939 |
| Borrowings | -0 | -0 | -0 | 250 | 250 | 250 | 250 | 250 |
| Other Liabilities | 737 | 891 | 1,322 | 1,983 | 2,799 | 3,891 | 5,735 | 7,240 |
| Total Liabilities | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 11,276 |
| Fixed Assets | 30 | 39 | 46 | 49 | 52 | 58 | 66 | 85 |
| CWIP | 2 | 2 | 2 | 1 | 4 | 1 | 9 | 3 |
| Investments | 816 | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 | 9,670 |
| Other Assets | 152 | 129 | 230 | 287 | 455 | 675 | 1,510 | 1,518 |
| Total Assets | 1,000 | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 9,760 | 11,276 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | — | — | 257 | 338 | 593 | 813 | 1,654 | 905 |
| Cash from Investing Activity | — | — | -374 | -723 | -829 | -1,882 | -2,348 | -961 |
| Cash from Financing Activity | — | — | 280 | 374 | 280 | 1,110 | 771 | -5 |
| Net Cash Flow | — | — | 164 | -12 | 43 | 41 | 78 | -62 |
| Free Cash Flow | — | — | 229 | 309 | 555 | 780 | 1,614 | 857 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | — | — | -1,180% | -75% | -180% | -720% | 2,000% | 577% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 55.98% | 55.98% | 55.43% | 55.41% | 55.36% | 55.36% | 55.30% |
| FIIs | 8.85% | 8.90% | 10.76% | 10.72% | 10.31% | 10.60% | 12.09% |
| DIIs | 9.82% | 9.71% | 15.06% | 15.31% | 16.04% | 16.49% | 16.17% |
| Public | 25.36% | 25.42% | 18.74% | 18.57% | 18.27% | 17.56% | 16.44% |
| No. of Shareholders | 1,46,255 | 1,36,017 | 1,54,883 | 1,58,550 | 1,47,718 | 1,35,343 | 1,26,567 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Inventory Days | — | — | — | — | — | — | — | — |
| Days Payable | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Working Capital Days | -264 | -270 | -290 | -341 | -313 | -298 | -351 | -354 |
| ROCE % | — | -19% | -10% | -30% | 1% | 5% | 7% | 3% |
Niva Bupa Health Ins Co L
₹14,239Cr.
₹77.0
₹91.4/67.5
81.7
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of NIVA BUPA HEALTH INS CO L (NIVABUPA)?
The reported market capitalisation for NIVA BUPA HEALTH INS CO L (NIVABUPA) is ₹14,239Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of NIVABUPA?
The current price shown for NIVA BUPA HEALTH INS CO L (NIVABUPA) on Fincrux is ₹77.0 with a 52-week high/low of ₹91.4/67.5.
What is the P/E ratio of NIVA BUPA HEALTH INS CO L (NIVABUPA)?
The stock P/E for NIVA BUPA HEALTH INS CO L (NIVABUPA) is 81.7 on Fincrux, with ROE at 3.46% and ROCE at 3.15%.
What were NIVABUPA latest quarterly results?
For Jun 2026, NIVA BUPA HEALTH INS CO L (NIVABUPA) reported sales ₹2,471 Cr and net profit ₹138 Cr (figures in ₹ crore unless noted).
What are NIVABUPA annual sales and net profit?
For TTM, NIVA BUPA HEALTH INS CO L (NIVABUPA) shows sales of ₹7,907 Cr and net profit of ₹174 Cr on the Fincrux profit & loss statement.
Who owns NIVA BUPA HEALTH INS CO L (NIVABUPA)?
Latest shareholding for NIVA BUPA HEALTH INS CO L (NIVABUPA) on Fincrux: Promoters 55.30% (Jun 2026), FIIs 12.09% (Jun 2026), DIIs 16.17% (Jun 2026), Public 16.44% (Jun 2026), No. of Shareholders 1,26,567% (Jun 2026).
Where can I find NIVA BUPA HEALTH INS CO L (NIVABUPA) financials?
NIVA BUPA HEALTH INS CO L (NIVABUPA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show NIVABUPA balance sheet and cash flow?
Yes. The NIVA BUPA HEALTH INS CO L (NIVABUPA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.